Ionogran--an ionomeric micro implant in bone tumour reconstruction. A clinical evaluation.
A new implant material, Ionogran (Ionos, Medizinische Produkte GmbH & Co. K.G., Germany), is evaluated in a series of 60 cases requiring augmented bone grafting for major bone defects. The material, an ionomeric porous micro implant (IMI), is stable, non-degradable, osteoconductive and biocompatible. It promotes the formation of osteoid and displays a dynamic surface activity which stimulates the process of repair. In the compromised situation of a large cavity following curettage and cryotherapy, Ionogran when mixed with a mulch of autogenous cancellous bone is a valuable filler, providing a direct osteoid bond with host bone, and a permanent scaffold which maintains shape, length and form of the affected part. It replaces allogenic bone grafts and the problems associated with that technique.
Lindeque
B G
BG
Musculo-Skeletal Tumour Unit, Orthopaedic Hospital, University of Pretoria, South Africa.
Jonck
L M
LM
D000293:Adolescent; D000328:Adult; D001859:Bone Neoplasms / Q000601:surgery*; D001861:Bone Regeneration / Q000502:physiology; D016025:Bone Transplantation / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods*; D002648:Child; D005069:Evaluation Studies as Topic; D005260:Female; D005500:Follow-Up Studies; D005899:Glass Ionomer Cements / Q000737:chemistry*; D006801:Humans; D008297:Male; D008422:Materials Testing; D008875:Middle Aged; D016062:Porosity; D011208:Powders